IBDEI09K ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4217,1,3,0)
 ;;=3^Potassium Hydroxide Preps
 ;;^UTILITY(U,$J,358.3,4218,0)
 ;;=87220^^20^256^4^^^^1
 ;;^UTILITY(U,$J,358.3,4218,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4218,1,2,0)
 ;;=2^87220
 ;;^UTILITY(U,$J,358.3,4218,1,3,0)
 ;;=3^Tissue Exam for Fungi
 ;;^UTILITY(U,$J,358.3,4219,0)
 ;;=17311^^20^257^1^^^^1
 ;;^UTILITY(U,$J,358.3,4219,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4219,1,2,0)
 ;;=2^17311
 ;;^UTILITY(U,$J,358.3,4219,1,3,0)
 ;;=3^MOHS 1 Stage H/N/HF/G
 ;;^UTILITY(U,$J,358.3,4220,0)
 ;;=17312^^20^257^2^^^^1
 ;;^UTILITY(U,$J,358.3,4220,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4220,1,2,0)
 ;;=2^17312
 ;;^UTILITY(U,$J,358.3,4220,1,3,0)
 ;;=3^MOHS H/N/HF/G,Ea Addl Stage
 ;;^UTILITY(U,$J,358.3,4221,0)
 ;;=17313^^20^257^3^^^^1
 ;;^UTILITY(U,$J,358.3,4221,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4221,1,2,0)
 ;;=2^17313
 ;;^UTILITY(U,$J,358.3,4221,1,3,0)
 ;;=3^MOHS 1 Stage T/A/L
 ;;^UTILITY(U,$J,358.3,4222,0)
 ;;=17314^^20^257^4^^^^1
 ;;^UTILITY(U,$J,358.3,4222,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4222,1,2,0)
 ;;=2^17314
 ;;^UTILITY(U,$J,358.3,4222,1,3,0)
 ;;=3^MOHS T/A/L,Ea Addl Stage
 ;;^UTILITY(U,$J,358.3,4223,0)
 ;;=17315^^20^257^5^^^^1
 ;;^UTILITY(U,$J,358.3,4223,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4223,1,2,0)
 ;;=2^17315
 ;;^UTILITY(U,$J,358.3,4223,1,3,0)
 ;;=3^MOHS Surg Addl Block
 ;;^UTILITY(U,$J,358.3,4224,0)
 ;;=96372^^20^258^8^^^^1
 ;;^UTILITY(U,$J,358.3,4224,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4224,1,2,0)
 ;;=2^96372
 ;;^UTILITY(U,$J,358.3,4224,1,3,0)
 ;;=3^Ther/Proph/Diag Inj SC/IM
 ;;^UTILITY(U,$J,358.3,4225,0)
 ;;=96406^^20^258^2^^^^1
 ;;^UTILITY(U,$J,358.3,4225,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4225,1,2,0)
 ;;=2^96406
 ;;^UTILITY(U,$J,358.3,4225,1,3,0)
 ;;=3^Chemo Intralesional > 7
 ;;^UTILITY(U,$J,358.3,4226,0)
 ;;=96405^^20^258^1^^^^1
 ;;^UTILITY(U,$J,358.3,4226,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4226,1,2,0)
 ;;=2^96405
 ;;^UTILITY(U,$J,358.3,4226,1,3,0)
 ;;=3^Chemo Intralesional Up to 7
 ;;^UTILITY(U,$J,358.3,4227,0)
 ;;=C9800^^20^258^3^^^^1
 ;;^UTILITY(U,$J,358.3,4227,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4227,1,2,0)
 ;;=2^C9800
 ;;^UTILITY(U,$J,358.3,4227,1,3,0)
 ;;=3^Dermal Filler Inj Px/Supply
 ;;^UTILITY(U,$J,358.3,4228,0)
 ;;=11901^^20^258^7^^^^1
 ;;^UTILITY(U,$J,358.3,4228,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4228,1,2,0)
 ;;=2^11901
 ;;^UTILITY(U,$J,358.3,4228,1,3,0)
 ;;=3^Skin Lesion Injection,Addl Lesions
 ;;^UTILITY(U,$J,358.3,4229,0)
 ;;=11900^^20^258^6^^^^1
 ;;^UTILITY(U,$J,358.3,4229,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4229,1,2,0)
 ;;=2^11900
 ;;^UTILITY(U,$J,358.3,4229,1,3,0)
 ;;=3^Skin Lesion Injection,Up to 7 Lesions
 ;;^UTILITY(U,$J,358.3,4230,0)
 ;;=Q2026^^20^258^4^^^^1
 ;;^UTILITY(U,$J,358.3,4230,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4230,1,2,0)
 ;;=2^Q2026
 ;;^UTILITY(U,$J,358.3,4230,1,3,0)
 ;;=3^Radiesse Inj 0.1 ml
 ;;^UTILITY(U,$J,358.3,4231,0)
 ;;=Q2028^^20^258^5^^^^1
 ;;^UTILITY(U,$J,358.3,4231,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4231,1,2,0)
 ;;=2^Q2028
 ;;^UTILITY(U,$J,358.3,4231,1,3,0)
 ;;=3^Sculptra Inj 0.5mg
 ;;^UTILITY(U,$J,358.3,4232,0)
 ;;=15780^^20^259^6^^^^1
 ;;^UTILITY(U,$J,358.3,4232,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4232,1,2,0)
 ;;=2^15780
 ;;^UTILITY(U,$J,358.3,4232,1,3,0)
 ;;=3^Dermabrasion,Total Face
 ;;^UTILITY(U,$J,358.3,4233,0)
 ;;=15781^^20^259^2^^^^1
 ;;^UTILITY(U,$J,358.3,4233,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4233,1,2,0)
 ;;=2^15781
 ;;^UTILITY(U,$J,358.3,4233,1,3,0)
 ;;=3^Dermabrasion,Segmental,Face
